Nvidia plans to invest in Avelios Medical, a Munich startup building what it calls an AI-native operating system for European hospitals, as part of a European spending push worth nearly $10B.
The investment size was not disclosed. Avelios was one of four German startups named by the chip company alongside robotics firm Agile Robots, audio startup Mirelo and space technology company Reflex Aerospace, announced while CEO Jensen Huang met German chancellor Friedrich Merz to discuss the country’s AI roadmap.
Why a new core
Avelios argues that bolting AI features onto legacy hospital software will not change care. Instead it rebuilt the core of hospital IT, combining structured clinical data, a modular architecture and treatment-oriented workflows into one system of record, so intelligence sits inside the care process rather than beside it.
“AI will only fundamentally change healthcare once it is seamlessly integrated into actual care,” co-founder and CEO Christian Albrecht said, adding that the breakthrough will not come from another AI application stacked on the dozens of systems clinicians already use.
Backers who know hospitals
The company already counts SAP and Fresenius among existing investors, pairing enterprise software expertise with deep healthcare operating experience. The Nvidia money would help scale operations and AI engineering teams and push the software into more hospitals, with planned investment in testing and validation of clinical workflow features.
The deal signals where Nvidia sees durable demand: not consumer AI but the unglamorous data plumbing of hospitals, where European buyers also care about sovereignty. For Avelios, the pitch is that the next generation of AI should not stand outside healthcare but become part of how care is delivered.
